OPERETTA 2 · WN42086
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase III multicenter, randomized, double-blind, double-dummy study to evaluate safety and efficacy of ocrelizumab in children and adolescents with relapsing-remitting multiple sclerosis
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology